<!DOCTYPE html>
<html lang="zh-CN">
<head>
  <meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=2">
<meta name="theme-color" content="#222">
<meta name="generator" content="Hexo 5.2.0">
  <link rel="apple-touch-icon" sizes="180x180" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="icon" type="image/png" sizes="32x32" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="icon" type="image/png" sizes="16x16" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico">
  <link rel="mask-icon" href="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/Logo2.ico" color="#222">

<link rel="stylesheet" href="/css/main.css">

<link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:300,300italic,400,400italic,700,700italic|14px:300,300italic,400,400italic,700,700italic&display=swap&subset=latin,latin-ext">
<link rel="stylesheet" href="/lib/font-awesome/css/all.min.css">
  <link rel="stylesheet" href="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.css">
  <link rel="stylesheet" href="/lib/pace/pace-theme-corner-indicator.min.css">
  <script src="/lib/pace/pace.min.js"></script>

<script id="hexo-configurations">
    var NexT = window.NexT || {};
    var CONFIG = {"hostname":"zhenyumi.github.io","root":"/","scheme":"Gemini","version":"7.8.0","exturl":false,"sidebar":{"position":"left","display":"post","padding":18,"offset":12,"onmobile":false},"copycode":{"enable":true,"show_result":true,"style":"mac"},"back2top":{"enable":true,"sidebar":false,"scrollpercent":true},"bookmark":{"enable":true,"color":"#000000","save":"auto"},"fancybox":{"enable":true,"caption":false},"mediumzoom":false,"lazyload":true,"pangu":true,"comments":{"style":"valine","active":null,"storage":true,"lazyload":false,"nav":null},"algolia":{"hits":{"per_page":10},"labels":{"input_placeholder":"Search for Posts","hits_empty":"We didn't find any results for the search: ${query}","hits_stats":"${hits} results found in ${time} ms"}},"localsearch":{"enable":true,"trigger":"auto","top_n_per_article":1,"unescape":false,"preload":false},"motion":{"enable":true,"async":true,"transition":{"post_block":"slideDownBigIn","post_header":"slideDownIn","post_body":"slideDownIn","coll_header":"slideLeftIn","sidebar":"slideUpIn"}},"path":"./public/search.xml"};
  </script>

  <meta name="description" content="Different drug receptors">
<meta property="og:type" content="article">
<meta property="og:title" content="L4 Drug Receptors &amp; Pharmacodynamics">
<meta property="og:url" content="https://zhenyumi.github.io/posts/c9f809bd.html">
<meta property="og:site_name" content="鹘横海">
<meta property="og:description" content="Different drug receptors">
<meta property="og:locale" content="zh_CN">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202237756.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202626609.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202659615.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202826694.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202959083.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203134943.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203257458.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203332282.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203340234.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203730998.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204050913.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204328898.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204857526.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205123930.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205156808.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205257899.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205318537.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205620730.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205641227.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315214914472.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315215630602.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220126347.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220248986.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220309971.png">
<meta property="og:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315221048117.png">
<meta property="article:published_time" content="2021-04-16T06:03:04.000Z">
<meta property="article:modified_time" content="2021-04-16T06:03:04.000Z">
<meta property="article:author" content="向海">
<meta property="article:tag" content="Molecular Pharmacology">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202237756.png">

<link rel="canonical" href="https://zhenyumi.github.io/posts/c9f809bd.html">


<script id="page-configurations">
  // https://hexo.io/docs/variables.html
  CONFIG.page = {
    sidebar: "",
    isHome : false,
    isPost : true,
    lang   : 'zh-CN'
  };
</script>

  <title>L4 Drug Receptors & Pharmacodynamics | 鹘横海</title>
  


  <script data-pjax>
    var _hmt = _hmt || [];
    (function() {
      var hm = document.createElement("script");
      hm.src = "https://hm.baidu.com/hm.js?aa95e0eb65e5b58f6500e4de221c0f67";
      var s = document.getElementsByTagName("script")[0];
      s.parentNode.insertBefore(hm, s);
    })();
  </script>




  <noscript>
  <style>
  .use-motion .brand,
  .use-motion .menu-item,
  .sidebar-inner,
  .use-motion .post-block,
  .use-motion .pagination,
  .use-motion .comments,
  .use-motion .post-header,
  .use-motion .post-body,
  .use-motion .collection-header { opacity: initial; }

  .use-motion .site-title,
  .use-motion .site-subtitle {
    opacity: initial;
    top: initial;
  }

  .use-motion .logo-line-before i { left: initial; }
  .use-motion .logo-line-after i { right: initial; }
  </style>
</noscript>

</head>

<body itemscope itemtype="http://schema.org/WebPage">
  <div class="container use-motion">
    <div class="headband"></div>

    <header class="header" itemscope itemtype="http://schema.org/WPHeader">
      <div class="header-inner"><div class="site-brand-container">
  <div class="site-nav-toggle">
    <div class="toggle" aria-label="切换导航栏">
      <span class="toggle-line toggle-line-first"></span>
      <span class="toggle-line toggle-line-middle"></span>
      <span class="toggle-line toggle-line-last"></span>
    </div>
  </div>

  <div class="site-meta">

    <a href="/" class="brand" rel="start">
      <span class="logo-line-before"><i></i></span>
      <h1 class="site-title">鹘横海</h1>
      <span class="logo-line-after"><i></i></span>
    </a>
      <p class="site-subtitle" itemprop="description">Hope tomorrow is still shining.  Today is another day.</p>
  </div>

  <div class="site-nav-right">
    <div class="toggle popup-trigger">
        <i class="fa fa-search fa-fw fa-lg"></i>
    </div>
  </div>
</div>




<nav class="site-nav">
  <ul id="menu" class="main-menu menu">
        <li class="menu-item menu-item-home">

    <a href="/" rel="section"><i class="fa fa-home fa-fw"></i>首页</a>

  </li>
        <li class="menu-item menu-item-about">

    <a href="/about/" rel="section"><i class="fa fa-user fa-fw"></i>关于</a>

  </li>
        <li class="menu-item menu-item-tags">

    <a href="/tags/" rel="section"><i class="fa fa-tags fa-fw"></i>标签<span class="badge">27</span></a>

  </li>
        <li class="menu-item menu-item-categories">

    <a href="/categories/" rel="section"><i class="fa fa-th fa-fw"></i>分类<span class="badge">24</span></a>

  </li>
        <li class="menu-item menu-item-archives">

    <a href="/archives/" rel="section"><i class="fa fa-archive fa-fw"></i>归档<span class="badge">201</span></a>

  </li>
        <li class="menu-item menu-item-留言板">

    <a href="/%E7%95%99%E8%A8%80%E6%9D%BF/" rel="section"><i class="fas fa-chalkboard-teacher fa-fw"></i>留言板</a>

  </li>
      <li class="menu-item menu-item-search">
        <a role="button" class="popup-trigger"><i class="fa fa-search fa-fw"></i>搜索
        </a>
      </li>
  </ul>
</nav>



  <div class="search-pop-overlay">
    <div class="popup search-popup">
        <div class="search-header">
  <span class="search-icon">
    <i class="fa fa-search"></i>
  </span>
  <div class="search-input-container">
    <input autocomplete="off" autocapitalize="off"
           placeholder="搜索..." spellcheck="false"
           type="search" class="search-input">
  </div>
  <span class="popup-btn-close">
    <i class="fa fa-times-circle"></i>
  </span>
</div>
<div id="search-result">
  <div id="no-result">
    <i class="fa fa-spinner fa-pulse fa-5x fa-fw"></i>
  </div>
</div>

    </div>
  </div>

</div>
    </header>

    
  <div class="back-to-top">
    <i class="fa fa-arrow-up"></i>
    <span>0%</span>
  </div>
  <div class="reading-progress-bar"></div>
  <a role="button" class="book-mark-link book-mark-link-fixed"></a>


    <main class="main">
      <div class="main-inner">
        <div class="content-wrap">
          

          <div class="content post posts-expand">
            

    
  
  
  <article itemscope itemtype="http://schema.org/Article" class="post-block" lang="zh-CN">
    <link itemprop="mainEntityOfPage" href="https://zhenyumi.github.io/posts/c9f809bd.html">

    <span hidden itemprop="author" itemscope itemtype="http://schema.org/Person">
      <meta itemprop="image" content="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
      <meta itemprop="name" content="向海">
      <meta itemprop="description" content="希望能活的久一点">
    </span>

    <span hidden itemprop="publisher" itemscope itemtype="http://schema.org/Organization">
      <meta itemprop="name" content="鹘横海">
    </span>
      <header class="post-header">
        <h1 class="post-title" itemprop="name headline">
          L4 Drug Receptors & Pharmacodynamics
        </h1>

        <div class="post-meta">
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-calendar"></i>
              </span>
              <span class="post-meta-item-text">发表于</span>

              <time title="创建时间：2021-04-16 14:03:04" itemprop="dateCreated datePublished" datetime="2021-04-16T14:03:04+08:00">2021-04-16</time>
            </span>
            <span class="post-meta-item">
              <span class="post-meta-item-icon">
                <i class="far fa-folder"></i>
              </span>
              <span class="post-meta-item-text">分类于</span>
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/" itemprop="url" rel="index"><span itemprop="name">Academic Notebook</span></a>
                </span>
                  ，
                <span itemprop="about" itemscope itemtype="http://schema.org/Thing">
                  <a href="/categories/Academic-Notebook/Molecular-Pharmacology/" itemprop="url" rel="index"><span itemprop="name">Molecular Pharmacology</span></a>
                </span>
            </span>

          
            <span class="post-meta-item" title="阅读次数" id="busuanzi_container_page_pv" style="display: none;">
              <span class="post-meta-item-icon">
                <i class="fa fa-eye"></i>
              </span>
              <span class="post-meta-item-text">阅读次数：</span>
              <span id="busuanzi_value_page_pv"></span>
            </span>
  
  <span class="post-meta-item">
    
      <span class="post-meta-item-icon">
        <i class="far fa-comment"></i>
      </span>
      <span class="post-meta-item-text">Valine：</span>
    
    <a title="valine" href="/posts/c9f809bd.html#valine-comments" itemprop="discussionUrl">
      <span class="post-comments-count valine-comment-count" data-xid="/posts/c9f809bd.html" itemprop="commentCount"></span>
    </a>
  </span>
  
  <br>
            <span class="post-meta-item" title="本文字数">
              <span class="post-meta-item-icon">
                <i class="far fa-file-word"></i>
              </span>
                <span class="post-meta-item-text">本文字数：</span>
              <span>10k</span>
            </span>

        </div>
      </header>

    
    
    
    <div class="post-body" itemprop="articleBody">

      
        <p><strong>Pharmacology</strong></p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202237756.png" alt="image-20210315202237756" style="zoom:100%;" />
<ul>
<li>Processes of drug action that occur when drug reaches site of action and produces an effect.</li>
</ul>
<h2 id="pharmocodynamic-phase"><a class="markdownIt-Anchor" href="#pharmocodynamic-phase"></a> Pharmocodynamic Phase</h2>
<p>Action vs. Effect</p>
<ul>
<li>action = how the drug works
<ul>
<li>usually by enhancing or inhibiting cell function</li>
</ul>
</li>
<li>effect = consequence of drug action on body</li>
</ul>
<p>Example: Aspirin</p>
<ul>
<li>action: block prostaglandin Synthesis， via binding and inhibiting cyclooxygenase</li>
<li>effect: analgesia &amp; antipyresis</li>
</ul>
<h2 id="how-drugs-act"><a class="markdownIt-Anchor" href="#how-drugs-act"></a> How drugs act</h2>
<p>Many drugs exert their actions by binding to protein targets on mammalian cells</p>
<ul>
<li>Receptors</li>
<li>Ion channels</li>
<li>Enzymes</li>
<li>Carrier molecules</li>
</ul>
<p>Exceptions</p>
<ul>
<li>Antibiotics (protein, DNA or lipid membrane)</li>
<li>Anti-cancer drugs (similar to above)</li>
<li>Etc.</li>
</ul>
<h2 id="drug-and-receptor-interaction"><a class="markdownIt-Anchor" href="#drug-and-receptor-interaction"></a> Drug and Receptor Interaction</h2>
<p>primary way drugs produce an action</p>
<ul>
<li>
<p>RECEPTOR</p>
<ul>
<li>The component of a cell or organism that interacts with a drug and initiates the chain of events leading to the drug’s observed effects</li>
</ul>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202626609.png" alt="image-20210315202626609" style="zoom:100%;" />
</li>
</ul>
<h2 id="receptor-types"><a class="markdownIt-Anchor" href="#receptor-types"></a> Receptor Types</h2>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202659615.png" alt="image-20210315202659615" style="zoom:100%;" />
<h3 id="1-intracellular-receptors-for-lipid-soluble-agents"><a class="markdownIt-Anchor" href="#1-intracellular-receptors-for-lipid-soluble-agents"></a> 1. Intracellular Receptors for Lipid-Soluble Agents</h3>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202826694.png" alt="image-20210315202826694" style="zoom:100%;" />
<ul>
<li>Several biologic signals are sufficiently lipid-soluble to cross the plasma membrane and act on intracellular receptors.</li>
<li>The ligands include steroids, sex steroids, vitamin D, and thyroid hormone</li>
</ul>
<p><strong>Therapeutical consequences of intracellular receptors</strong></p>
<ul>
<li>transcription and translation take about 30 min</li>
<li>All of these hormones (ligands) produce their effects after a period of 30 minutes to several hours</li>
<li>The effects of these agents can persist for hours or days after the agonist concentration has been reduced to zero</li>
</ul>
<h3 id="2-ligand-gated-channels"><a class="markdownIt-Anchor" href="#2-ligand-gated-channels"></a> 2. Ligand-Gated Channels</h3>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315202959083.png" alt="image-20210315202959083" style="zoom: 50%;" />
<p>The open of channel results in the flow of ion and thereby alters the electrical potential across the membrane</p>
<ul>
<li>The natural ligands including N-acetylcholine, excitatory amino acids (glycine, glutamate, etc), γ-GABA (Cl-, chlorine).</li>
<li>All of these agents are synaptic transmitters</li>
</ul>
<p>The time scale of signaling is about milliseconds</p>
<p>The rapidity of this signaling is crucially important for moment transfer of information across synapses</p>
<h3 id="3-g-protein-coupled-receptors"><a class="markdownIt-Anchor" href="#3-g-protein-coupled-receptors"></a> 3. G-protein-coupled Receptors</h3>
<p>This is the largest receptors family with over a hundred members cloned to date</p>
<p>G-protein: a kind of GTP-binding proteins with subunit of αβγ</p>
<p>Characteristics: seven-times crossing the plasma membrane, use G protein as transducers to convey signal to their effector proteins</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203134943.png" alt="image-20210315203134943" style="zoom:100%;" />
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203257458.png" alt="image-20210315203257458" style="zoom:100%;" />
<p>Members: include receptors for many biogenic amines, such as adrenalin, DA, histamine, M-acetylcholine, and others.</p>
<p>G-protein-regulated effectors include enzymes such as <strong>adenylyl cyclase</strong> and phospholipase C and plasma membrane ion channels.</p>
<h4 id="well-established-second-messengers"><a class="markdownIt-Anchor" href="#well-established-second-messengers"></a> Well-Established Second Messengers</h4>
<p>metabolite or ion that diffuse through a cell to convey information</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203332282.png" alt="image-20210315203332282" style="zoom:100%;" />
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203340234.png" alt="image-20210315203340234" style="zoom:100%;" />
<p>Is synthesized by adenylyl cyclase under the control of many G protein-coupled receptors</p>
<p>Is eliminated by a combination of hydrolysis, catalyzed by phosphodiesterases, and extrusion by several plasma membrane transport proteins</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315203730998.png" alt="image-20210315203730998" style="zoom:100%;" />
<ul>
<li>Activate <strong>cyclic AMP-dependent protein kinases</strong> (PKA)</li>
<li>The <strong>PKA</strong> can phosphorylate both final physiological targets and numerous protein kinases and other regulatory proteins, Including transcription factors to regulate gene expression</li>
</ul>
<h4 id="cyclic-amp"><a class="markdownIt-Anchor" href="#cyclic-amp"></a> Cyclic AMP</h4>
<p>These kinases are composed of a cAMP-binding domain and catalytic chains</p>
<p>The <strong>PKA</strong> can phosphorylate both final physiological targets and numerous protein kinases and other regulatory proteins, including transcription factors</p>
<ul>
<li>Regulate gene expression</li>
</ul>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204050913.png" alt="image-20210315204050913" style="zoom:100%;" />
<h4 id="calcium-and-phosphoinositides"><a class="markdownIt-Anchor" href="#calcium-and-phosphoinositides"></a> Calcium and Phosphoinositides</h4>
<p>Phospholipase C splits the phosphatidylinositol-4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol-1,4,5trisphosphate (IP3)</p>
<ul>
<li>DAG is confined to the membrane and activates a phospholipid and calcium-sensitive protein kinase called <strong>protein kinase C.</strong></li>
<li>IP3 triggers release of Ca2+ from internal storage vesicles</li>
</ul>
<h3 id="4-ligand-regulated-transmembrane-enzymes-including-receptor-tyrosine-kinases"><a class="markdownIt-Anchor" href="#4-ligand-regulated-transmembrane-enzymes-including-receptor-tyrosine-kinases"></a> 4. Ligand-Regulated Transmembrane Enzymes Including Receptor Tyrosine Kinases</h3>
<p>Be composed of an extracelluar ligand-binding domain and a cytoplasmic enzyme domain (protein tyrosine/serine (threonine) kinase or a guanylyl cyclase)</p>
<p>Insulin, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and many other trophic hormones.</p>
<p>Ligand bind, conformation change, receptors bind to one another, tyrosine residues cross-phosphorylated</p>
<p>Activated receptors catalyze phosphorylation of tyrosine residues in their substrates</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204328898.png" alt="image-20210315204328898" style="zoom:100%;" />
<h4 id="therapeutical-consequences"><a class="markdownIt-Anchor" href="#therapeutical-consequences"></a> Therapeutical consequences</h4>
<p>Inhibitors of receptor tyrosine kinases are finding increased use in neoplastic disorders</p>
<p>Ligand binding often induces accelerated endocytosis of receptors from the cell surface and degradation (down-regulation)</p>
<h2 id="theory-and-assumptions-of-drug-receptor-interaction"><a class="markdownIt-Anchor" href="#theory-and-assumptions-of-drug-receptor-interaction"></a> Theory and assumptions of drug-receptor interaction</h2>
<p>Binding to receptor causes some event which leads to the response.</p>
<p>Response to a drug is graded or dose-dependent.</p>
<p>For a given drug, the magnitude of response is directly proportional to the fraction of total receptor sites occupied by drug molecules (i.e. the occupancy assumption).</p>
<p>The number of drug molecules is assumed to be much greater than the number of receptor sites.</p>
<p>Binding of drug with a receptor produces a specific response. “lock and key”.</p>
<p>Drug-receptor interactions are analogous to enzyme-substrate interactions.</p>
<ul>
<li>Endogenous ligands (e.g. enkephalin versus morphine).</li>
<li>Drugs without specific receptors (e.g. gaseous anesthetics).</li>
</ul>
<h1 id="drug-and-receptor-interaction-2"><a class="markdownIt-Anchor" href="#drug-and-receptor-interaction-2"></a> Drug and receptor interaction</h1>
<p>Drug receptor interaction follows simple mass-action relationships, i.e., only one drug molecule occupies each receptor site and binding is reversible. Can be described with <strong>Michaelis Menten equation</strong>:</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315204857526.png" alt="image-20210315204857526" style="zoom: 50%;" />
<p>When a drug (D) combines with a receptor ®, it does so at a rate which is dependent on the concentration of the drug and the concentration of the receptor</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205123930.png" alt="image-20210315205123930" style="zoom: 67%;" />
<p>D = drug</p>
<p>R = receptor,</p>
<p>DR = drug-receptor complex</p>
<p>k1 = rate for association</p>
<p>k2 = rate for dissociation.</p>
<p>KD = Dissociation Constant</p>
<p>KA = Association Constant</p>
<h2 id="saturation-curve"><a class="markdownIt-Anchor" href="#saturation-curve"></a> Saturation curve</h2>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205156808.png" alt="image-20210315205156808" style="zoom: 50%;" />
<p>A. Total binding<br />
B. Nonspecific binding<br />
C. Difference=Specific binding</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205257899.png" alt="image-20210315205257899" style="zoom:100%;" />
<p>RT= Total number of receptors</p>
<p>Bmax = Maximal number of receptors Bound</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205318537.png" alt="image-20210315205318537" style="zoom:100%;" />
<p>At equilibrium, the dissociation constant is KD and the affinity is KA= 1/KD Thus when [D] =KD, half the total number of receptors will be occupied.</p>
<h2 id="terminology"><a class="markdownIt-Anchor" href="#terminology"></a> Terminology</h2>
<p>Terms which indicate ability of drug to bind to receptor</p>
<ul>
<li>Potency</li>
<li>Affinity (1/KD)</li>
<li>KD or ED50 (Effective dose 50)</li>
<li>(Corresponds to Km in Michaelis-Menten analogy)</li>
</ul>
<h2 id="concentration-bound-receptors"><a class="markdownIt-Anchor" href="#concentration-bound-receptors"></a> Concentration-Bound Receptors</h2>
<p>Bmax indicates the total concentration of receptor sites</p>
<p>KD represents the concentration of free drug at which half-maximal binding is observed</p>
<p>This constant characterizes the receptor’s affinity for binding the drug in a reciprocal fashion</p>
<p>The EC50 and Kd may be identical, but need not be</p>
<h2 id="relation-between-drug-concentration-and-response"><a class="markdownIt-Anchor" href="#relation-between-drug-concentration-and-response"></a> Relation Between Drug Concentration and Response</h2>
<p>D-E relationship of patient</p>
<p>C-E relationship of in vitro system</p>
<p><strong>Concentration-Effect Curves &amp; Receptor Binding of Agonists</strong></p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205620730.png" alt="image-20210315205620730" style="zoom:100%;" />
<p><strong>Concentration-Effect Curves</strong></p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315205641227.png" alt="image-20210315205641227" style="zoom:100%;" />
<ul>
<li>If plotted the E versus log D or log C, the curve become typical symmetrical sigmoid curve.</li>
<li>Expands the low and compresses high concentration</li>
</ul>
<h2 id="classification-of-drugs-based-on-pd"><a class="markdownIt-Anchor" href="#classification-of-drugs-based-on-pd"></a> Classification of Drugs based on PD</h2>
<p><strong>Antagonist</strong></p>
<ul>
<li>A pure antagonist, which can bind to receptors without efficacy, antagonizes the biologic effects of the corresponding agonist.</li>
<li>Competitive &amp; Irreversible Antagonists
<ul>
<li>Antagonists are divided into two classes depending on whether or not they reversibly compete with agonists for binding to receptors</li>
<li>Competitive antagonist</li>
<li>Noncompetitive/irreversible antagonist</li>
<li><strong>Competitive antagonist</strong>
<ul>
<li>Competes the same receptor with agonist and reversibly binds to receptors</li>
<li>The Emax for the agonist remains the same for any fixed concentration of antagonist</li>
<li>The presence of antagonist will increase the ED50 of the agonist</li>
<li>So the D-E curve of agonist will shift to the right</li>
<li>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315214914472.png" alt="image-20210315214914472" style="zoom:100%;" />
</li>
<li><strong>Therapeutic Implications</strong>
<ul>
<li>The degree of inhibition produced by a competitive antagonist depends on the concentration of antagonist. D→C</li>
<li>Clinical response to a competitive antagonist depends on the concentration of agonist that is competing for binding to receptors</li>
</ul>
</li>
</ul>
</li>
<li><strong>Non-competitive antagonist</strong>
<ul>
<li>Irreversibly binds to receptors</li>
<li>The antagonism can not be overcome by increasing the concentration of the agonist, that is to say the maximal effects of the agonist are depressed by the corresponding noncompetitive antagonist</li>
<li>make the height of the curve descend.</li>
<li>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315215630602.png" alt="image-20210315215630602" style="zoom:100%;" />
</li>
<li><strong>Therapeutic Implications</strong>
<ul>
<li>Therapeutically, irreversible antagonists present distinctive advantages and disadvantages</li>
<li>Consequently, the duration of action of such an irreversible antagonist is relatively independent of its own rate of elimination and more dependent on the rate of turnover of receptor molecules</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<p><strong>Agonist</strong></p>
<ul>
<li>
<p>Can bind to receptors, then activate receptors and produce pharmacological effect.</p>
</li>
<li>
<p>Agonist I drugs (direct agonists)</p>
<ul>
<li>bind to same site as endogenous ligand</li>
<li>effect? similar to ligand</li>
</ul>
</li>
<li>
<p>Agonist II drugs (indirect agonists)</p>
<ul>
<li>bind to different cell site
<ul>
<li>do not produce effect themselves</li>
<li>enhance effect of natural ligand</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Partial Agonists</strong></p>
</li>
<li>
<p>Based on the maximal pharmacologic response that occurs when all receptors are occupied, agonist can be divided into two classes:</p>
<ul>
<li>Partial agonists produce a lower response, at full receptor occupancy, than do full agonists</li>
<li>The effects of full agonists can be considered more efficiently coupled to receptor occupancy than can the effects of partial agonists
<ul>
<li>Partial agonists produce C-E curves that resemble those observed with full agonists in the presence of irreversible antagonists</li>
<li>The failure of partial agonists to produce a maximal response is not due to decreased affinity for binding to receptors <u>(low intrinsic activity)</u></li>
<li>Partial agonists competitively inhibit the responses produced by full agonists</li>
</ul>
</li>
</ul>
</li>
</ul>
<h2 id="dose-effect-relationship"><a class="markdownIt-Anchor" href="#dose-effect-relationship"></a> Dose-effect Relationship</h2>
<p>In a certain range of doses, the pharmacological response is increased in proportion with the increase in doses.</p>
<h2 id="dose-response-curve"><a class="markdownIt-Anchor" href="#dose-response-curve"></a> Dose-response curve</h2>
<p>The dose-effect curve can be obtained from plotting the pharmacological effect intension (E) as y axis versus dosage (D) or concentration © of drugs as x axis</p>
<h2 id="dose-response-in-patients"><a class="markdownIt-Anchor" href="#dose-response-in-patients"></a> Dose &amp; Response in Patients</h2>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220126347.png" alt="image-20210315220126347" />
<h3 id="1-graded-response"><a class="markdownIt-Anchor" href="#1-graded-response"></a> 1. Graded response</h3>
<p>In a certain range of doses, the pharmacological response increases with the increasing of doses.</p>
<p>blood pressure, muscle contraction, urinary excretion of sodium</p>
<h3 id="2-quantal-response-or-all-or-none-response"><a class="markdownIt-Anchor" href="#2-quantal-response-or-all-or-none-response"></a> 2. Quantal response or all-or-none response</h3>
<p>Indicate that a given dose of a drug has or has not evoked a certain effect in the various subjects under investigation.</p>
<p>Expressed with all or none, positive or negative, e.g., death or survival, convulsion or not, paralysis or not</p>
<h2 id="potency"><a class="markdownIt-Anchor" href="#potency"></a> Potency</h2>
<p>Refers to the concentration (EC50) or dose (ED50) of a drug required to produce 50% of that drug’s maximal effect.</p>
<ul>
<li>What is mean more potent?
<ul>
<li>Nitroglycerin is very potent; relatively few molecules need to absorbed to produce the therapeutic effect</li>
</ul>
</li>
<li>If the drug is to be administered by transdermal absorption, a highly potent drug is required, since the capacity of the skin to absorb drugs is limited</li>
</ul>
<p>SEMILOG DOSE-RESPONSE CURVE</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220248986.png" alt="image-20210315220248986" style="zoom:100%;" />
<h2 id="maximal-efficacy"><a class="markdownIt-Anchor" href="#maximal-efficacy"></a> Maximal Efficacy</h2>
<p>The maximal effect that can be produced by a drug is its maximal efficacy. It reflects the limit of the dose-response relation on the response axis</p>
<p>The maximal efficacy of a drug for achieving a therapeutic end point may be limited by the drug’s propensity to cause a toxic effect even if the drug could otherwise produce a greater therapeutic effect</p>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315220309971.png" alt="image-20210315220309971" style="zoom:100%;" />
<h2 id="median-effect-dose-ed50"><a class="markdownIt-Anchor" href="#median-effect-dose-ed50"></a> Median effect dose (ED50)</h2>
<p>For all-or-none responses, the dose of a drug that gives rise to a response in 50% of the subjects is called ED50</p>
<p>It provide a convenient way of comparing the potencies of drugs in experimental and clinical settings</p>
<h3 id="1-meanings-of-ed50"><a class="markdownIt-Anchor" href="#1-meanings-of-ed50"></a> 1. Meanings of ED50</h3>
<p>If the ED50s of two drugs for producing a specified quantal effect are 5 and 500 mg, respectively, then：</p>
<ul>
<li>One can obtain a valuable index of the selectivity of a drug’s action by comparing its ED50s for two different quantal effects in a population</li>
<li>Eg, cough suppression versus sedation for opioid drugs</li>
</ul>
<h2 id="median-lethal-dose-ld50"><a class="markdownIt-Anchor" href="#median-lethal-dose-ld50"></a> Median lethal dose (LD50)</h2>
<p>A dose that gives rise to the death of 50% of subjects is called LD50</p>
<p>LD50 is a primary index evaluated the safety of a drug, but it can not reflect the relationship between drug effect and toxic effect.</p>
<h2 id="therapeutic-index-ti"><a class="markdownIt-Anchor" href="#therapeutic-index-ti"></a> Therapeutic index (TI)</h2>
<img data-src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Articles/Academic_Notes/Molecular%20Pharmacology/image-20210315221048117.png" alt="image-20210315221048117" style="zoom:100%;" />
<p>Is a measure which relates the dose of a drug required to produce a desired effect to that which produces an undesired effect -denotes the safety of the drugs</p>
<p>TI=LD50/ED50 （LC50/EC50）</p>
<ul>
<li>The larger value of the TI is, the wider margin between effective dose and toxic dose is. For example, the drug of TI=4 is more safe than that of TI=2.</li>
</ul>

    </div>

    
    
    

      <footer class="post-footer">
          
          <div class="post-tags">
              <a href="/tags/Molecular-Pharmacology/" rel="tag"><i class="fa fa-tag"></i> Molecular Pharmacology</a>
          </div>

        


        
    <div class="post-nav">
      <div class="post-nav-item">
    <a href="/posts/434f152.html" rel="prev" title="L3 Pharmacokinetics">
      <i class="fa fa-chevron-left"></i> L3 Pharmacokinetics
    </a></div>
      <div class="post-nav-item">
    <a href="/posts/aec0f5de.html" rel="next" title="L5 Autonomic pharmacology: cholinergic and anti cholinergic drugs">
      L5 Autonomic pharmacology: cholinergic and anti cholinergic drugs <i class="fa fa-chevron-right"></i>
    </a></div>
    </div>
      </footer>
    
  </article>
  
  
  



          </div>
          
    <div class="comments" id="valine-comments"></div>

<script>
  window.addEventListener('tabs:register', () => {
    let { activeClass } = CONFIG.comments;
    if (CONFIG.comments.storage) {
      activeClass = localStorage.getItem('comments_active') || activeClass;
    }
    if (activeClass) {
      let activeTab = document.querySelector(`a[href="#comment-${activeClass}"]`);
      if (activeTab) {
        activeTab.click();
      }
    }
  });
  if (CONFIG.comments.storage) {
    window.addEventListener('tabs:click', event => {
      if (!event.target.matches('.tabs-comment .tab-content .tab-pane')) return;
      let commentClass = event.target.classList[1];
      localStorage.setItem('comments_active', commentClass);
    });
  }
</script>

        </div>
          
  
  <div class="toggle sidebar-toggle">
    <span class="toggle-line toggle-line-first"></span>
    <span class="toggle-line toggle-line-middle"></span>
    <span class="toggle-line toggle-line-last"></span>
  </div>

  <aside class="sidebar">
    <div class="sidebar-inner">

      <ul class="sidebar-nav motion-element">
        <li class="sidebar-nav-toc">
          文章目录
        </li>
        <li class="sidebar-nav-overview">
          站点概览
        </li>
      </ul>

      <!--noindex-->
      <div class="post-toc-wrap sidebar-panel">
          <div class="post-toc motion-element"><ol class="nav"><li class="nav-item nav-level-2"><a class="nav-link" href="#pharmocodynamic-phase"><span class="nav-text"> Pharmocodynamic Phase</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#how-drugs-act"><span class="nav-text"> How drugs act</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#drug-and-receptor-interaction"><span class="nav-text"> Drug and Receptor Interaction</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#receptor-types"><span class="nav-text"> Receptor Types</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#theory-and-assumptions-of-drug-receptor-interaction"><span class="nav-text"> Theory and assumptions of drug-receptor interaction</span></a></li></ol></li><li class="nav-item nav-level-1"><a class="nav-link" href="#drug-and-receptor-interaction-2"><span class="nav-text"> Drug and receptor interaction</span></a><ol class="nav-child"><li class="nav-item nav-level-2"><a class="nav-link" href="#saturation-curve"><span class="nav-text"> Saturation curve</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#terminology"><span class="nav-text"> Terminology</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#concentration-bound-receptors"><span class="nav-text"> Concentration-Bound Receptors</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#relation-between-drug-concentration-and-response"><span class="nav-text"> Relation Between Drug Concentration and Response</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#classification-of-drugs-based-on-pd"><span class="nav-text"> Classification of Drugs based on PD</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#dose-effect-relationship"><span class="nav-text"> Dose-effect Relationship</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#dose-response-curve"><span class="nav-text"> Dose-response curve</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#dose-response-in-patients"><span class="nav-text"> Dose &amp; Response in Patients</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#potency"><span class="nav-text"> Potency</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#maximal-efficacy"><span class="nav-text"> Maximal Efficacy</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#median-effect-dose-ed50"><span class="nav-text"> Median effect dose (ED50)</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#median-lethal-dose-ld50"><span class="nav-text"> Median lethal dose (LD50)</span></a></li><li class="nav-item nav-level-2"><a class="nav-link" href="#therapeutic-index-ti"><span class="nav-text"> Therapeutic index (TI)</span></a></li></ol></div>
      </div>
      <!--/noindex-->

      <div class="site-overview-wrap sidebar-panel">
        <div class="site-author motion-element" itemprop="author" itemscope itemtype="http://schema.org/Person">
    <img class="site-author-image" itemprop="image" alt="向海"
      src="https://hexo20200628-1259353497.cos.ap-guangzhou.myqcloud.com/Others/next/pixil-frame-0.png">
  <p class="site-author-name" itemprop="name">向海</p>
  <div class="site-description" itemprop="description">希望能活的久一点</div>
</div>
<div class="site-state-wrap motion-element">
  <nav class="site-state">
      <div class="site-state-item site-state-posts">
          <a href="/archives/">
        
          <span class="site-state-item-count">201</span>
          <span class="site-state-item-name">日志</span>
        </a>
      </div>
      <div class="site-state-item site-state-categories">
            <a href="/categories/">
          
        <span class="site-state-item-count">24</span>
        <span class="site-state-item-name">分类</span></a>
      </div>
      <div class="site-state-item site-state-tags">
            <a href="/tags/">
          
        <span class="site-state-item-count">27</span>
        <span class="site-state-item-name">标签</span></a>
      </div>
  </nav>
</div>
  <div class="links-of-author motion-element">
      <span class="links-of-author-item">
        <a href="mailto:zhenyumi@foxmail.com" title="E-Mail → mailto:zhenyumi@foxmail.com" rel="noopener" target="_blank"><i class="fa fa-envelope fa-fw"></i>E-Mail</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://weibo.com/u/2279880515" title="Weibo → https:&#x2F;&#x2F;weibo.com&#x2F;u&#x2F;2279880515" rel="noopener" target="_blank"><i class="fab fa-weibo fa-fw"></i>Weibo</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://twitter.com/ParaDogs_lazy" title="Twitter → https:&#x2F;&#x2F;twitter.com&#x2F;ParaDogs_lazy" rel="noopener" target="_blank"><i class="fab fa-twitter fa-fw"></i>Twitter</a>
      </span>
      <span class="links-of-author-item">
        <a href="https://t.me/Furemu" title="Telegram → https:&#x2F;&#x2F;t.me&#x2F;Furemu" rel="noopener" target="_blank"><i class="fab fa-telegram fa-fw"></i>Telegram</a>
      </span>
  </div>


<!-- none-select-br -->

<p></p>

<!-- hitokoto -->

<div class="hitokoto-title">
	<i class="fa fa-paragraph"></i>
	<b>一言</b>
</div>

<div id="hitokoto">获取中OvO</div>
<i id="hitofrom">获取中OvO</i>

<script src="https://cdn.jsdelivr.net/npm/bluebird@3/js/browser/bluebird.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/whatwg-fetch@2.0.3/fetch.min.js"></script>
<script>
  fetch('https://v1.hitokoto.cn/?c=i')
    .then(function (res){
      return res.json();
    })
    .then(function (data) {
      var hitokoto = document.getElementById('hitokoto');
      hitokoto.innerText = '\xa0\xa0\xa0\xa0\xa0\xa0\xa0' + data.hitokoto;
      var hitofrom = document.getElementById('hitofrom');
      hitofrom.innerText = "——" + data.from + '\xa0'; 
    })
    .catch(function (err) {
      console.error(err);
    })
</script>
      </div>

    </div>
  </aside>
  <div id="sidebar-dimmer"></div>


      </div>
    </main>

    <footer class="footer">
      <div class="footer-inner">
        

        

<div class="copyright">
  
  &copy; 2020 – 
  <span itemprop="copyrightYear">2021</span>
  <span class="with-love">
    <i class="fa fa-heart"></i>
  </span>
  <span class="author" itemprop="copyrightHolder">向海</span>
    <span class="post-meta-divider">|</span>
    <span class="post-meta-item-icon">
      <i class="fa fa-chart-area"></i>
    </span>
      <span class="post-meta-item-text">站点总字数：</span>
    <span title="站点总字数">2.8m</span>
    <span class="post-meta-divider">|</span>
    <span class="post-meta-item-icon">
      <i class="fa fa-coffee"></i>
    </span>
      <span class="post-meta-item-text">站点阅读时长 &asymp;</span>
    <span title="站点阅读时长">42:18</span>
</div><br /> <!-- 换行 -->

<div class="translate-style">
繁/简：<a id="translateLink" href="javascript:translatePage();">繁体
</a>
</div>
<script type="text/javascript" src="/js/tw_cn.js"></script>
<script type="text/javascript">
var defaultEncoding = 2; //网站编写字体是否繁体，1-繁体，2-简体
var translateDelay = 0; //延迟时间,若不在前, 要设定延迟翻译时间, 如100表示100ms,默认为0
var cookieDomain = "https://tding.top/"; //Cookie地址, 一定要设定, 通常为你的网址
var msgToTraditionalChinese = "繁体"; //此处可以更改为你想要显示的文字
var msgToSimplifiedChinese = "简体"; //同上，但两处均不建议更改
var translateButtonId = "translateLink"; //默认互换id
translateInitilization();
</script>

<!-- 网站运行时间的设置 -->
<span id="timeDate">载入天数...</span>
<span id="times">载入时分秒...</span>
<script>
    var now = new Date();
    function createtime() {
        var grt= new Date("06/01/2020 12:00:00");//此处修改你的建站时间或者网站上线时间
        now.setTime(now.getTime()+250);
        days = (now - grt ) / 1000 / 60 / 60 / 24; dnum = Math.floor(days);
        hours = (now - grt ) / 1000 / 60 / 60 - (24 * dnum); hnum = Math.floor(hours);
        if(String(hnum).length ==1 ){hnum = "0" + hnum;} minutes = (now - grt ) / 1000 /60 - (24 * 60 * dnum) - (60 * hnum);
        mnum = Math.floor(minutes); if(String(mnum).length ==1 ){mnum = "0" + mnum;}
        seconds = (now - grt ) / 1000 - (24 * 60 * 60 * dnum) - (60 * 60 * hnum) - (60 * mnum);
        snum = Math.round(seconds); if(String(snum).length ==1 ){snum = "0" + snum;}
        document.getElementById("timeDate").innerHTML = "已正常运行 "+dnum+" 天";
        document.getElementById("times").innerHTML = hnum + " 小时 " + mnum + " 分 " + snum + " 秒 OvO";
    }
setInterval("createtime()",250);
</script>

<br /> <!-- 换行 -->

<!--busuanzi计数-->

    <script async src="//dn-lbstatics.qbox.me/busuanzi/2.3/busuanzi.pure.mini.js"></script>

    <span id="busuanzi_container_site_pv">总访问量<span id="busuanzi_value_site_pv"></span>次</span>
    <span class="post-meta-divider">|</span>
    <span id="busuanzi_container_site_uv">总访客数<span id="busuanzi_value_site_uv"></span>人</span>
    <span class="post-meta-divider">|</span>
<!-- 不蒜子计数初始值纠正 -->
<script>
$(document).ready(function() {

    var int = setInterval(fixCount, 50);  // 50ms周期检测函数
    var countOffset = 20000;  // 初始化首次数据

    function fixCount() {            
       if (document.getElementById("busuanzi_container_site_pv").style.display != "none")
        {
            $("#busuanzi_value_site_pv").html(parseInt($("#busuanzi_value_site_pv").html()) + countOffset); 
            clearInterval(int);
        }                  
        if ($("#busuanzi_container_site_pv").css("display") != "none")
        {
            $("#busuanzi_value_site_uv").html(parseInt($("#busuanzi_value_site_uv").html()) + countOffset); // 加上初始数据 
            clearInterval(int); // 停止检测
        }  
    }
       	
});
</script> 



        
<div class="busuanzi-count">
  <script data-pjax async src="https://busuanzi.ibruce.info/busuanzi/2.3/busuanzi.pure.mini.js"></script>
    <span class="post-meta-item" id="busuanzi_container_site_pv" style="display: none;">
      <span class="post-meta-item-icon">
        <i class="fa fa-eye"></i>
      </span>
      <span class="site-pv" title="总访问量">
        <span id="busuanzi_value_site_pv"></span>
      </span>
    </span>
</div>








      </div>
    </footer>
  </div>

  
  <script src="/lib/anime.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/theme-next/theme-next-pjax@0/pjax.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/jquery@3/dist/jquery.min.js"></script>
  <script src="//cdn.jsdelivr.net/gh/fancyapps/fancybox@3/dist/jquery.fancybox.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/lozad@1/dist/lozad.min.js"></script>
  <script src="//cdn.jsdelivr.net/npm/pangu@4/dist/browser/pangu.min.js"></script>
  <script src="/lib/velocity/velocity.min.js"></script>
  <script src="/lib/velocity/velocity.ui.min.js"></script>

<script src="/js/utils.js"></script>

<script src="/js/motion.js"></script>


<script src="/js/schemes/pisces.js"></script>


<script src="/js/next-boot.js"></script>

<script src="/js/bookmark.js"></script>

  <script>
var pjax = new Pjax({
  selectors: [
    'head title',
    '#page-configurations',
    '.content-wrap',
    '.post-toc-wrap',
    '.languages',
    '#pjax'
  ],
  switches: {
    '.post-toc-wrap': Pjax.switches.innerHTML
  },
  analytics: false,
  cacheBust: false,
  scrollTo : !CONFIG.bookmark.enable
});

window.addEventListener('pjax:success', () => {
  document.querySelectorAll('script[data-pjax], script#page-configurations, #pjax script').forEach(element => {
    var code = element.text || element.textContent || element.innerHTML || '';
    var parent = element.parentNode;
    parent.removeChild(element);
    var script = document.createElement('script');
    if (element.id) {
      script.id = element.id;
    }
    if (element.className) {
      script.className = element.className;
    }
    if (element.type) {
      script.type = element.type;
    }
    if (element.src) {
      script.src = element.src;
      // Force synchronous loading of peripheral JS.
      script.async = false;
    }
    if (element.dataset.pjax !== undefined) {
      script.dataset.pjax = '';
    }
    if (code !== '') {
      script.appendChild(document.createTextNode(code));
    }
    parent.appendChild(script);
  });
  NexT.boot.refresh();
  // Define Motion Sequence & Bootstrap Motion.
  if (CONFIG.motion.enable) {
    NexT.motion.integrator
      .init()
      .add(NexT.motion.middleWares.subMenu)
      .add(NexT.motion.middleWares.postList)
      .bootstrap();
  }
  NexT.utils.updateSidebarPosition();
});
</script>




  




  
<script src="/js/local-search.js"></script>









<script data-pjax>
document.querySelectorAll('.pdfobject-container').forEach(element => {
  let url = element.dataset.target;
  let pdfOpenParams = {
    navpanes : 0,
    toolbar  : 0,
    statusbar: 0,
    pagemode : 'thumbs',
    view     : 'FitH'
  };
  let pdfOpenFragment = '#' + Object.entries(pdfOpenParams).map(([key, value]) => `${key}=${encodeURIComponent(value)}`).join('&');
  let fullURL = `/lib/pdf/web/viewer.html?file=${encodeURIComponent(url)}${pdfOpenFragment}`;

  if (NexT.utils.supportsPDFs()) {
    element.innerHTML = `<embed class="pdfobject" src="${url + pdfOpenFragment}" type="application/pdf" style="height: ${element.dataset.height};">`;
  } else {
    element.innerHTML = `<iframe src="${fullURL}" style="height: ${element.dataset.height};" frameborder="0"></iframe>`;
  }
});
</script>


<script data-pjax>
if (document.querySelectorAll('pre.mermaid').length) {
  NexT.utils.getScript('//cdn.jsdelivr.net/npm/mermaid@8/dist/mermaid.min.js', () => {
    mermaid.initialize({
      theme    : 'forest',
      logLevel : 3,
      flowchart: { curve     : 'linear' },
      gantt    : { axisFormat: '%m/%d/%Y' },
      sequence : { actorMargin: 50 }
    });
  }, window.mermaid);
}
</script>


    <div id="pjax">
  

  
      
<link rel="stylesheet" href="//cdn.jsdelivr.net/npm/katex@0/dist/katex.min.css">
  <script src="//cdn.jsdelivr.net/npm/katex@0/dist/contrib/copy-tex.min.js"></script>
  <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/katex@0/dist/contrib/copy-tex.min.css">


  
  <script src="//cdn.jsdelivr.net/npm/quicklink@1/dist/quicklink.umd.js"></script>
  <script>
      window.addEventListener('load', () => {
      quicklink({
        timeout : 3000,
        priority: true,
        ignores : [uri => uri.includes('#'),uri => uri === 'https://zhenyumi.github.io/posts/c9f809bd.html',]
      });
      });
  </script>


<script>
NexT.utils.loadComments(document.querySelector('#valine-comments'), () => {
  NexT.utils.getScript('//cdn.jsdelivr.net/npm/valine@1/dist/Valine.min.js', () => {
    var GUEST = ['nick', 'mail', 'link'];
    var guest = 'nick,mail,link';
    guest = guest.split(',').filter(item => {
      return GUEST.includes(item);
    });
    new Valine({
      el         : '#valine-comments',
      verify     : false,
      notify     : true,
      appId      : 'ErV27FWAFsY2HDPhLVjeIcfR-MdYXbMMI',
      appKey     : 'YyUrjqWLM53k8C1tPcKNaQFN',
      placeholder: "Leave Something?",
      avatar     : 'mm',
      meta       : guest,
      pageSize   : '10' || 10,
      visitor    : false,
      lang       : 'zh-ch' || 'zh-cn',
      path       : location.pathname,
      recordIP   : true,
      serverURLs : ''
    });
  }, window.Valine);
});
</script>

    </div>
</body>
</html>
